NATH BIO-GENES (INDIA) LTD (NATHBIOGEN)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 235.28 22.57 31.74 43.04 243.88 32.19 36.87 51.97 283.70 43.85 65.96 51.59
YOY Revenue Growth % - - - -4.33% 3.65% 42.65% 16.18% 20.75% 16.33% 36.21% 78.88% -0.72%
Other Income 0.12 0.06 0.04 0.41 0.13 0.08 0.48 3.86 1.76 1.93 1.74 2.38
Total Income 235.40 22.63 31.78 43.45 244.01 32.27 37.35 55.83 285.46 45.78 67.69 53.97
Total Expenses + 145.12 18.48 20.32 107.19 150.81 15.60 103.21 54.26 249.59 42.39 67.90 52.74
Cost of Materials Consumed 69.42 5.66 8.36 59.02 66.39 0.69 86.87 101.60 108.85 21.80 106.33 69.20
Employee Benefit Expense 7.19 7.85 5.99 7.17 6.74 8.94 10.49 6.34 9.59 10.39 11.61 4.21
Other Expenses 68.50 4.96 5.97 41.00 77.69 5.98 5.86 27.53 96.00 10.25 22.00 27.11
Operating Profit 90.17 4.09 11.42 -64.15 93.06 16.59 -66.34 -2.29 34.11 1.46 -1.94 -1.14
OPM % 38.3% 18.1% 36% -149.1% 38.2% 51.5% -179.9% -4.4% 12% 3.3% -2.9% -2.2%
Profit Before Tax + 33.40 2.38 4.59 3.23 33.60 1.09 3.79 2.11 37.94 5.46 2.48 2.49
Tax Expense 0.22 0.31 0.75 0.62 0.25 -0.03 1.14 0.63 0.66 2.70 0.87 2.50
Tax % 0.7% 13.1% 16.4% 19% 0.7% -2.5% 30.1% 29.8% 1.7% 49.6% 35.2% 100.4%
Profit After Tax 33.18 2.07 3.83 2.62 33.35 1.11 2.65 1.48 37.28 2.75 1.61 -0.01
EPS (Basic) 17.47 0.86 2.02 1.87 17.49 0.53 1.33 1.14 19.58 1.40 0.84 -0.79

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 364.91 332.62 301.36
YOY Revenue Growth % 9.71% 10.37% -
Other Income 4.55 0.63 0.55
Total Income 369.45 333.25 301.92
Total Expenses + 329.41 291.66 235.33
Cost of Materials Consumed 225.54 142.47 117.32
Employee Benefit Expense 32.50 28.25 23.32
Other Expenses 147.06 120.94 94.69
Operating Profit 35.50 40.97 66.03
OPM % 9.7% 12.3% 21.9%
Profit Before Exceptional 40.04 38.12 36.16
Exceptional Items 0.54 3.45 0.00
Profit Before Tax + 40.58 41.57 36.16
Tax Expense 1.98 1.95 1.14
Tax % 4.9% 4.7% 3.1%
Profit After Tax 38.60 39.62 35.03
EPS (Basic) 20.14 21.34 18.42

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 336.20 308.57 271.97
Property, Plant & Equipment 243.19 240.65 233.96
Capital Work in Progress 0.00 0.00 0.00
Non-Current Investments 5.78 8.81 5.05
Goodwill 0.00 0.00 0.00
Other Intangible Assets 7.18 0.00 10.42
Current Assets + 690.01 571.66 520.83
Inventories 338.02 230.31 207.85
Trade Receivables 88.90 94.31 97.31
Cash and Cash Equivalents 88.90 77.41 38.00
Current Investments 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00
Equity Share Capital 19.00 19.00 19.00
Other Equity 625.38 590.91 554.17
Non-Current Liabilities 16.52 7.87 3.17
Current Liabilities 365.30 262.45 216.45
Total Liabilities 381.82 270.31 219.62

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 17.58 70.28 38.37
Cash from Investing Activities -3.96 -27.40 -2.88
Cash from Financing Activities -2.13 -4.51 -1.67
Net Increase/Decrease in Cash 11.49 38.37 33.82